Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Hyaluronidase + triamcinolone** is a combination of two drugs used primarily in dermatology and musculoskeletal medicine. Hyaluronidase is an enzyme that breaks down hyaluronic acid in the extracellular matrix, increasing tissue permeability and enhancing the dispersion and absorption of co-administered drugs. Triamcinolone is a synthetic corticosteroid with potent anti-inflammatory properties, commonly used to reduce inflammation, suppress immune responses, and treat various inflammatory conditions. When combined, these agents are administered via intralesional or intra-articular injection to treat conditions such as keloids, hypertrophic scars, and adhesive capsulitis (frozen shoulder). The combination leverages the anti-inflammatory effects of triamcinolone with the spreading/enhancing action of hyaluronidase for improved efficacy and reduced side effects compared to monotherapy[4][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on hyaluronidase + triamcinolone.